Tags

Type your tag names separated by a space and hit enter

Disparities in Provider Recommendation of Human Papillomavirus Vaccination for U.S. Adolescents.
J Adolesc Health. 2016 11; 59(5):592-598.JA

Abstract

PURPOSE

To determine the prevalence of and examine factors associated with provider recommendation of human papillomavirus vaccination for U.S. adolescents.

METHODS

Multivariable logistic regression analyses were performed using data from the National Immunization Survey-Teen 2014 on 34,478 adolescents aged 13-17 years.

RESULTS

Overall prevalence of vaccine recommendation was 72.6% for girls and 51.8% for boys. Lower rates were observed among girls aged 13 years, living below poverty line, adolescents of lesser educated mothers, and those residing in the South. Overall, girls had higher odds of vaccine recommendation (odds ratio [OR] = 2.57; 95% confidence interval [CI] = 2.35-2.82). Correlates of higher vaccine recommendation for girls were: older age-17 versus 13 (OR = 1.51; 95% CI = 1.20-1.89), living above versus below poverty line, and residing in Northeast (OR = 1.45; 95% CI = 1.21-1.73) and Midwest (OR = 1.29; 95% CI = 1.11-1.50) versus South. For boys, correlates of higher vaccine recommendation were: non-Hispanic black (OR = 1.30; 95% CI = 1.07-1.58) and Hispanic (OR = 1.24; 95% CI = 1.03-1.48) versus non-Hispanic white race and residing in Northeast (OR = 1.79; 95% CI = 1.54-2.08) and West (OR = 1.41; 95% CI = 1.17-1.70) versus South. Other factors associated with vaccine recommendation were having a college-educated mother and frequent doctor visits in the past 12 months.

CONCLUSIONS

This study highlights significant disparities in provider recommendation of human papillomavirus vaccination for U.S. adolescents. Findings suggest possible areas for tailored interventions to bridge the gap in vaccine recommendation and uptake in high-risk populations.

Authors+Show Affiliations

St Louis University Center for Outcomes Research (SLUCOR), St Louis University, St Louis, Missouri. Electronic address: kmohamm2@slu.edu.Department of Biostatistics and Bioinformatics, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana.Department of Epidemiology, College for Public Health and Social Justice, St Louis University, St Louis, Missouri; Department of Otolaryngology-Head and Neck Surgery, School of Medicine, St Louis University, St Louis, Missouri; St Louis University Cancer Center, St Louis, Missouri.St Louis University Center for Outcomes Research (SLUCOR), St Louis University, St Louis, Missouri.Department of Epidemiology, College for Public Health and Social Justice, St Louis University, St Louis, Missouri.St Louis University Center for Outcomes Research (SLUCOR), St Louis University, St Louis, Missouri.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

27506278

Citation

Mohammed, Kahee A., et al. "Disparities in Provider Recommendation of Human Papillomavirus Vaccination for U.S. Adolescents." The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine, vol. 59, no. 5, 2016, pp. 592-598.
Mohammed KA, Geneus CJ, Osazuwa-Peters N, et al. Disparities in Provider Recommendation of Human Papillomavirus Vaccination for U.S. Adolescents. J Adolesc Health. 2016;59(5):592-598.
Mohammed, K. A., Geneus, C. J., Osazuwa-Peters, N., Adjei Boakye, E., Tobo, B. B., & Burroughs, T. E. (2016). Disparities in Provider Recommendation of Human Papillomavirus Vaccination for U.S. Adolescents. The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine, 59(5), 592-598. https://doi.org/10.1016/j.jadohealth.2016.06.005
Mohammed KA, et al. Disparities in Provider Recommendation of Human Papillomavirus Vaccination for U.S. Adolescents. J Adolesc Health. 2016;59(5):592-598. PubMed PMID: 27506278.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Disparities in Provider Recommendation of Human Papillomavirus Vaccination for U.S. Adolescents. AU - Mohammed,Kahee A, AU - Geneus,Christian J, AU - Osazuwa-Peters,Nosayaba, AU - Adjei Boakye,Eric, AU - Tobo,Betelihem B, AU - Burroughs,Thomas E, Y1 - 2016/08/06/ PY - 2016/03/11/received PY - 2016/06/08/revised PY - 2016/06/09/accepted PY - 2016/10/25/pubmed PY - 2018/2/6/medline PY - 2016/8/11/entrez KW - Adolescent KW - HPV vaccine KW - Human papillomavirus KW - NIS-Teen KW - Provider KW - Recommendation SP - 592 EP - 598 JF - The Journal of adolescent health : official publication of the Society for Adolescent Medicine JO - J Adolesc Health VL - 59 IS - 5 N2 - PURPOSE: To determine the prevalence of and examine factors associated with provider recommendation of human papillomavirus vaccination for U.S. adolescents. METHODS: Multivariable logistic regression analyses were performed using data from the National Immunization Survey-Teen 2014 on 34,478 adolescents aged 13-17 years. RESULTS: Overall prevalence of vaccine recommendation was 72.6% for girls and 51.8% for boys. Lower rates were observed among girls aged 13 years, living below poverty line, adolescents of lesser educated mothers, and those residing in the South. Overall, girls had higher odds of vaccine recommendation (odds ratio [OR] = 2.57; 95% confidence interval [CI] = 2.35-2.82). Correlates of higher vaccine recommendation for girls were: older age-17 versus 13 (OR = 1.51; 95% CI = 1.20-1.89), living above versus below poverty line, and residing in Northeast (OR = 1.45; 95% CI = 1.21-1.73) and Midwest (OR = 1.29; 95% CI = 1.11-1.50) versus South. For boys, correlates of higher vaccine recommendation were: non-Hispanic black (OR = 1.30; 95% CI = 1.07-1.58) and Hispanic (OR = 1.24; 95% CI = 1.03-1.48) versus non-Hispanic white race and residing in Northeast (OR = 1.79; 95% CI = 1.54-2.08) and West (OR = 1.41; 95% CI = 1.17-1.70) versus South. Other factors associated with vaccine recommendation were having a college-educated mother and frequent doctor visits in the past 12 months. CONCLUSIONS: This study highlights significant disparities in provider recommendation of human papillomavirus vaccination for U.S. adolescents. Findings suggest possible areas for tailored interventions to bridge the gap in vaccine recommendation and uptake in high-risk populations. SN - 1879-1972 UR - https://www.unboundmedicine.com/medline/citation/27506278/Disparities_in_Provider_Recommendation_of_Human_Papillomavirus_Vaccination_for_U_S__Adolescents_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1054-139X(16)30139-2 DB - PRIME DP - Unbound Medicine ER -